ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

EMBC Embecta Corporation

10,39
0,24 (2,36%)
Après les heures de négociation
Dernière mise à jour : 00:29:39
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Embecta Corporation EMBC NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,24 2,36% 10,39 00:29:39
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
10,23 10,15 10,41 10,39 10,15
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202423:00GLOBEembecta to Participate in Investor Events
23/4/202423:00GLOBEembecta to Report Fiscal Second Quarter 2024 Financial..
06/3/202412:00GLOBEembecta-sponsored Educational Symposium and Abstracts at..
14/2/202416:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:30EDGAR2Form 8-K - Current report
09/2/202418:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/2/202412:52EDGAR2Form 8-K - Current report
09/2/202412:30GLOBEEmbecta Corp. Reports First Quarter Fiscal 2024 Financial..
09/2/202412:00GLOBEembecta Announces Quarterly Cash Dividend
07/2/202423:00GLOBEembecta to Participate in the 11th Annual BTIG MedTech..
24/1/202423:00GLOBEembecta to Report Fiscal First Quarter 2024 Financial..
09/1/202412:00GLOBEembecta Announces FDA 510(k) Submission for Insulin Patch..
19/12/202322:18EDGAR2Form ARS - Annual Report to Security Holders
19/12/202322:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/12/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
14/12/202323:00GLOBEembecta to Participate at the 42nd Annual J.P. Morgan..
01/12/202312:00GLOBENo embecta-made syringes impacted by FDA safety..
29/11/202323:00GLOBEembecta to Participate in Investor Conferences
29/11/202322:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/11/202302:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202302:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202302:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202312:11EDGAR2Form 8-K - Current report
21/11/202311:30GLOBEEmbecta Corp. Reports Fiscal 2023 Fourth Quarter and Full..
21/11/202311:00GLOBEembecta Announces Quarterly Cash Dividend
31/10/202311:50GLOBEembecta to Recognize National Diabetes Awareness Month by..
25/10/202323:00GLOBEembecta to Report Fiscal Fourth Quarter and Full Year 2023..
06/9/202323:00GLOBEembecta to Participate at the Morgan Stanley 21st Annual..
10/8/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202319:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:06EDGAR2Form 8-K - Current report
08/8/202312:30GLOBEEmbecta Corp. Reports Third Quarter Fiscal 2023 Financial..
08/8/202312:00GLOBEembecta Announces Quarterly Cash Dividend
03/8/202322:16EDGAR2Form 8-K - Current report
11/7/202323:00GLOBEembecta to Report Fiscal Third Quarter 2023 Financial..
05/7/202323:10EDGAR2Form 8-K - Current report
15/5/202323:38GLOBEUPDATE -- embecta to Participate in Investor Conferences
15/5/202323:00GLOBEembecta to Participate in Investor Conferences
12/5/202312:30GLOBEEmbecta Corp. Reports Second Quarter Fiscal 2023 Financial..
12/5/202312:15GLOBEembecta and Tidepool partner to develop automated insulin..
12/5/202312:00GLOBEembecta Announces Quarterly Cash Dividend

Dernières Valeurs Consultées

Delayed Upgrade Clock